Hemp-derived CBD supplement maker Elixinol shed half of its global workforce and shuttered production lines in the first half of this year in response to market decline stemming from the global COVID-19 pandemic. Now the Australian company is looking to leverage a leaner operation and focus on its core CBD brands for future success. Talking […]
2020 survival strategies: Why Elixinol cut half its workforce, halted production and refocused for future growth is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
From 2020 survival strategies: Why Elixinol cut half its workforce, halted production and refocused for future growth on CBD Products & CBD Business News – Hemp Industry Daily.
This was autoposted by IFTTT. To find out more, read my post about news articles.
No comments:
Post a Comment